How the new drug for the treatment of advanced pancreatic cancer works: It is taken orally, once a day

The United States Food and Drug Administration (FDA) has approved daraxonrasib, a new oral medication administered once daily for the treatment of advanced pancreatic cancer. The drug was specifically designed to block one of the most frequently altered molecular pathways associated with this type of cancer.

In concurrent international and corporate developments, Brazil has officially launched the television and radio propaganda phase of its presidential campaign amid rising corruption suspicions surrounding the circles of President Luiz Inácio Lula da Silva and Flávio Bolsonaro. Meanwhile, in the corporate sector, the engineering firm Revenga is finalizing its sale to Lantania for 20,4 million euros following its voluntary filing for creditors' contest last December.